AMPICILLIN SODIUM Recall D-0592-2023
Description: Ampicillin and Sulbactam for Injection, USP 1.5 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-005-20
AMPICILLIN SODIUM Recall D-0592-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0592-2023 |
| Event ID | 92341 |
| Brand | AMPICILLIN AND SULBACTAM |
| Generic Name | AMPICILLIN SODIUM AND SULBACTAM SODIUM |
| Manufacturer | AMPICILLIN SODIUM AND SULBACTAM SODIUM |
| Original Package? | 1 |
| Active Substance | AMPICILLIN SODIUM SULBACTAM SODIUM |
| Drug Route | INTRAMUSCULAR |
| Distribution | Nationwide within the United States |
| Quantity | 236,610 vials |
| Recall Reason | Lack of Assurance of Sterility |
| Drug Classification | Class II |
| Drug Code Info | 20230524 |
| Product NDC | 71288-005 71288-006 |
| Recall Initiation Date | 20230515 |
| Report Date | 20230524 |
| Classification Date | 20230518 |
| Address | 911 G I D C Makarpura Vadodara, India |
| Recalling Firm | Astral SteriTech Private Ltd. |
| Initial Notification | Letter |
| Unique Ingredient Identifier | JFN36L5S8K DKQ4T82YE6 |
| Drug Application Number | ANDA090579 |
| Structured Product Labeling (SPL ID) | 83e30d31-47ce-4d16-81b0-bfc568e21d89 |
| Structured Product Labeling (SPL Set ID) | 6ae2c4a1-f704-4642-bbdd-f69a9ef07605 |
| Similar To |